Regulatory registration procedure for COVID19 diagnosis medical devices maximally accelerated in Russia

29

May 2020

As part of efforts to increase the effectiveness of measures to prevent the spread of coronavirus infection, the Ministry of Health of Russia informed suppliers, manufacturers and executive authorities that, subject to the rules for submitting documents for registration of medical devices intended for the diagnosis of coronavirus infection, their registration will be carried out as soon as possible deadlines.

In addition to accredited laboratories, technical and clinical trials of such medical devices can be carried out by the All-Russian Scientific Research and Testing Institute of Medical Technology of Roszdravnadzor (Federal Service for Healthcare Surveillance). The Institute also provides free consultations on issues related to the state registration of medical devices intended for the diagnosis of coronavirus infection.

The Russian Ministry of Health also notes that a detailed elaboration by the manufacturer (applicant) of the registration documentation and test approaches, together with experts subordinate to Roszdravnadzor expert institutions, will provide not only a high-quality level of evidence of the effectiveness of the medical device but also a high speed of its entry into the market.

See the full details here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.

The latest related news

18

Mar 2022

On February 22, 2022, a repository of innovative acts outside the nomenclature of biology and anatomopathology (RIHN) and a Supplementary list of IVD tests were published. Minor changes were introduced in the 2022 RIHN list.

Read more

25

Feb 2022

The Council for Choices in Health Care in Finland (PALKO) has discontinued the development of recommendations concerning companion diagnostic tests. The respective preparations were completed in November 2021.

Read more

23

Feb 2022

On January 24, 2022, the Norwegian Directorate of e-Health released an updated version of the National Laboratory code (NLK) system and associated tariffs for state and private laboratories to be implemented no later than March 01, 2022. NLK system has been used for activity-based reimbursement by the Norwegian Health Economics Administration (Helfo) in outpatient settings since 2018. Thirty new codes were added medical biochemistry, medical microbiology, immunology and transfusiology, and clinical pharmacology areas.

Read more

26

Jan 2022

On January 14, 2022, the Government of the Russian Federation released a Decree which approved the inclusion of three devices (implantable pulse generator for urinary/fecal incontinence, bioprosthetic aortic valve/xenoprosthesis, and vessels embolization material) in the List of Essential Implantable Medical Devices.

Read more

20

Jan 2022

In December 2021, nineteen clinical guidelines relating to cardiovascular, gastrointestinal, men’s health, peripheral vascular, and other disease areas were released in Russia.

Read more